Centro Sociosanitario Nuestra Señora del Pino

Se trata de visibilizar y mostrar las desigualdades de género en el marco de la diversidad cultural, en un contexto de multiculturalidad transcultural jerarquizada en Mallorca como sociedad receptora. Para constatar estos planteamientos se realizaron entrevistas en profundidad a mujeres afro-ecuatorianas y originarias, emigradas de Suramérica hacia Mallorca, registrando sus respuestas en un cuestionario-guía preestablecido. Éste fue contestado por 39 mujeres de origen étnico afro-ecuatoriano y originarias de Ecuador, Colombia y Bolivia. Estas mujeres constituyen una muestra y un ejemplo significativo de la feminización de la migración y la supervivencia colectiva. The aim is to make visible and show gender inequalities within the framework of cultural diversity, in a context of hierarchical cross-cultural multiculturalism in Mallorca as a host society. In order to verify these approaches, in-depth interviews were conducted with Afro-Ecuadorian women and indigenous natives, emigrated from South America to Mallorca, recording their responses in a pre-established questionnaire-guide. This was answered by 39 women of Afro-Ecuadorian and indigenous ethnicity from Ecuador, Colombia and Bolivia. They represent a significant aspect of the feminization of migration and collective survival.

A 19 pacientes operados de cirugía cardíaca con circulación extracorpórea (CEC) se les realizó un lavado broncoalveolar (LBA) momentos antes (1." LBA) y después (2.° LBA) de la CEC. Comparando los resultados del recuento celular del 1." LBA con el 2.° LBA se ha visto en este último un mayor número de neutrófilos, hecho indicativo de una posible agresión sobre el pulmón mducida por la CEC. 
 
 Se revisa bibliografía relevante sobre el secuestro de neutrófilos en el pulmón en pacientes sometidos a operaciones cardíacas con CEC.

Seven cases of solitary fibrous tumours of the pleura are here reported, formerly named benign fibrous mesotheliomas. Histologically, these tumours are formed by fusiform cells with a minimal cellular pleomorphism and absence of mitosis. These tumours cause scarce symptoms which are usually diagnosed as a casual finding when a chest X-ray is performed on account of other cause. Treatment should be surgical, with removal of all tumoral mass, thus avoiding its growth and the possibility of the reported degeneration towards malignancy.

SUMMARYA randomised, double‐blind trial was undertaken to investigate the efficacy and tolerability of formoterol Turbuhaler® in children with mild to moderate asthma. After a two‐week run‐in, 248 children aged 6–17 years were randomised to receive formoterol 4.5 and 9 ug b.i.d. or placebo for 12 weeks. Morning PEF (primary variable), was significantly improved versus placebo only in the formoterol 9 ug b.i.d. group (13 l/min, 95% CI: 1.9, 24.2%; p=0.02). Both formoterol 4.5 and 9 ug significantly increased the pre‐bronchodilator FEV1 by 5.2–6.7% (p<0.05) and reduced use of daytime relief medication versus placebo (p<0.05). Formoterol 9 ug significantly reduced night‐time reliever use and awakenings due to asthma versus placebo (p<0.05). Both doses of formoterol were as well tolerated as placebo. In conclusion, formoterol 4.5 and 9 μg b.i.d. is effective and well tolerated as maintenance therapy in children with mild to moderate asthma.

Conventional continuous ambulatory peritoneal dialysis (CAPD) in patients without residual renal function and with high solute transport is associated with worse clinical outcomes. Automated peritoneal dialysis (APD) has the potential to improve both solute clearance and ultrafiltration in these circumstances, but its efficacy as a treatment modality is unknown. The European Automated Peritoneal Dialysis Outcomes Study (EAPOS) is a 2-year, prospective, European multicenter study designed to determine APD feasibility and clinical outcomes in anuric patients. The present article describes the baseline data for patients recruited into the study. All PD patients treated in the participating centers were screened for inclusion criteria [urinary output < 100 mL/24 h, or residual renal function (RRF) < 1 mL/min, or both]. After enrollment, changes were made to the dialysis prescription to achieve a weekly creatinine clearance above 60 L per 1.73 m2 and an ultrafiltration rate above 750 mL in 24 hours. The study is being conducted in 26 dialysis centers in 13 European countries. BASELINE DATA COLLECTION: The information collected includes patient demographics, dialysis prescription, achieved weekly creatinine clearance, and 24-hour ultrafiltration (UF). The study enrolled 177 anuric patients. Median dialysis duration before enrollment was 22.5 months (range: 0-285 months). Mean solute transport measured as the dialysate-to-plasma ratio of creatinine (D/P(Cr)) was 0.74 +/- 0.12. Patients received APD for a median of 9.0 hours overnight (range: 7-12 hours) using a median of 11.0 L of fluid (range: 6-28.75 L). Median daytime volume was 4.0 L (range: 0.0-9.0 L). Tidal dialysis was used in 26 patients, and icodextrin in 86 patients. At baseline, before treatment optimization, the weekly mean total creatinine clearance was 65.2 +/- 14.4 L/1.73 m2, with 105 patients (60%) achieving the target of more than 60 L/1.73 m2. At baseline, 81% of patients with high transport, 69% with high-average transport, and 40% with low-average transport met the target. At baseline, 70% of patients with a body surface area (BSA) below 1.7 m2, 60% with a BSA of 1.7-2.0 m2, and 56% with a BSA above 2.0 m2 achieved 60 L/1.73 m2 weekly. Median UF was 1090 mL/24 h, and 75% of patients achieved the UF target of more than 750 mL/24 h. This baseline analysis of anuric patients recruited into the EAPOS study demonstrates that a high proportion of anuric patients on APD can achieve dialysis and ultrafiltration targets using a variety of regimes. This 2-year follow-up study aims to optimize APD prescription to reach predefined clearance and ultrafiltration targets, and to observe the resulting clinical outcomes.

The general classification of head injury proposed by Marshall et al., based on admission CT scan findings, might mask a group of patients who have Diffuse Brain Injury (DI) in addition to intracranial haematomas. The aim of this study was to assess possible differences in outcome with respect to the level of intracranial pressure (ICP) and cerebral perfusion pressure (CPP) between a group of patients with DI: III-IV (Marshall's classification) after the evacuation of an intracranial haematoma (group A) and another group with DI: III-IV in the absence of a mass lesion (group B). We prospectively studied 129 patients with isolated and closed severe head injury (GCS < 9). In group A (n = 61), the median percentage of hours with ICP > 20 mmHg and CPP < 70 mmHg was 42.8 and 18, respectively and 17 (28%) survived with GOS 4-5. In group B (n = 68), median values of 20 and 5.5 hours were obtained for ICP > 20 and CPP < 70 respectively, whilst 39 (57.3%) survived with favourable outcomes. When we analysed the effects of the DI: III-IV in both groups of patients, we found that the differences in percentage of time with ICP > 20 and CPP < 70 were statistically significant (p < 0.01) and patients in group A had a higher morbidity and mortality (p < 0.05). This study has demonstrated that the levels of ICP, morbidity and mortality in patients with DI: III-IV and an evacuated mass lesion were higher than in patients with DI: III-IV without a mass lesion.